title: Questionnaire for a biotech: NovaDigm Therapeutics.
authors: NovaDigm Therapeutics Inc.; Grand Forks, ND USA.
authors: John P
authors: JP
authors: Hennessey
authors: Tim
authors: T
authors: Cooke
mesh_terms: D002181:Candidiasis, Vulvovaginal / Q000517:prevention & control*; D017321:Clinical Trials, Phase I as Topic; D055808:Drug Discovery / Q000639:trends; D005260:Female; D005657:Fungal Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000235:genetics / Q000276:immunology*; D006801:Humans; D055502:Secondary Prevention; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000009:adverse effects / Q000235:genetics / Q000276:immunology
chemical_list: D005657:Fungal Vaccines; D014614:Vaccines, Synthetic